Stanniocalcin-2 Inhibits Mammalian Growth by Proteolytic Inhibition of the Insulin-like Growth Factor Axis
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Mammalian stanniocalcin-2 (STC2) is a secreted polypeptide widely expressed in developing and adult tissues. However, although transgenic expression in mice is known to cause severe dwarfism, and targeted deletion of STC2 causes increased postnatal growth, its precise biological role is still unknown. We found that STC2 potently inhibits the proteolytic activity of the growth-promoting metalloproteinase, pregnancy-associated plasma protein-A (PAPP-A). Proteolytic inhibition requires covalent binding of STC2 to PAPP-A and is mediated by a disulfide bond, which involves Cys-120 of STC2. Binding of STC2 prevents PAPP-A cleavage of insulin-like growth factor-binding protein (IGFBP)-4 and hence release within tissues of bioactive IGF, required for normal growth. Concordantly, we show that STC2 efficiently inhibits PAPP-A-mediated IGF receptor signaling in vitro and that transgenic mice expressing a mutated variant of STC2, STC2(C120A), which is unable to inhibit PAPP-A, grow like wild-type mice. Our work identifies STC2 as a novel proteinase inhibitor and a previously unrecognized extracellular component of the IGF system. Background: The biological function and biochemical activity of mammalian stanniocalcin-2 are unknown. Results: Stanniocalcin-2 inhibits proteolytic release of insulin-like growth factor (IGF), and its ability to cause growth retardation upon transgenic overexpression in mice depends on its proteinase inhibitory function. Conclusion: Stanniocalcin-2 is a novel component of the IGF axis. Significance: Altered stanniocalcin-2 expression may affect IGF signaling under pathological conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Efficient selection for high-expression transfectants with a novel eukaryotic vector
Hitoshi, N., Ken-ichi, Y., & Jun-ichi, M. (1991) · Gene · doi:10.1016/0378-1119(91)90434-d · Cited by 5,134
Insulin-Like Growth Factors and Their Binding Proteins: Biological Actions*
JONES, J. I., & CLEMMONS, D. R. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-1-3 · Cited by 4,710 · cited 1×
“IGF signaling is mediated by the type 1 IGF receptor (IGF1R),(3) but six high affinity IGF-binding proteins, IGFBP-1 to 6, are able to sequester the IGFs from the receptor (3, 4).”
BackgroundUsing circular dichroism spectra to estimate protein secondary structure
Greenfield, N. J. (2006) · Nature Protocols · doi:10.1038/nprot.2006.202 · Cited by 4,014 · cited 1×
“Circular Dichroism (CD) Analysis—Purified wild-type and mutant proteins were compared by using circular dichroism analysis (37).”
MethodHundreds of variants clustered in genomic loci and biological pathways affect human height
Lango Allen, H., Estrada, K., Lettre, G., Berndt, S. I., Weedon, M. N., Rivadeneira, F., Willer, C. J., Jackson, A. U., Vedantam, S., Raychaudhuri, S., et al. (2010) · Nature · doi:10.1038/nature09410 · Cited by 1,945 · cited 1×
“In humans, adult height is influenced by genetic variants distributed in a large number of loci (44).”
BackgroundDeChiara, T. M., Efstratiadis, A., & Robertsen, E. J. (1990) · Nature · doi:10.1038/345078a0 · Cited by 1,642 · cited 1×
“In agreement with this mechanism, PAPP-A null mice (17) and IGF-II null mice (18) both have a 40% reduced body mass compared with wild-type littermates.”
BackgroundNormal growth and development in the absence of hepatic insulin-like growth factor I
Yakar, S., Liu, J.-L., Stannard, B., Butler, A., Accili, D., Sauer, B., & LeRoith, D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7324 · Cited by 1,420 · cited 1×
“The source of IGF within tissues may be the circulation or cells of the tissue, first emphasized by the finding that liver-specific knock-out of IGF-I dramatically reduces (by 75%) serum levels of IGF-I but has no effect on growth (42, 43).”
BackgroundThe insulin and insulin-like growth factor receptor family in neoplasia: an update
Pollak, M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3215 · Cited by 1,116 · cited 1×
“Dysregulated IGF receptor signaling has been extensively linked to various diseases, in particular human cancer (53).”
BackgroundSjögren, K., Liu, J.-L., Blad, K., Skrtic, S., Vidal, O., Wallenius, V., LeRoith, D., Törnell, J., Isaksson, O. G. P., Jansson, J.-O., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.7088 · Cited by 938 · cited 1×
“The source of IGF within tissues may be the circulation or cells of the tissue, first emphasized by the finding that liver-specific knockout of IGF-I dramatically reduces (by 75%) serum levels of IGF-I, but has no effect on growth (42,43).”
BackgroundStewart, C. E., & Rotwein, P. (1996) · Physiological Reviews · doi:10.1152/physrev.1996.76.4.1005 · Cited by 776 · cited 1×
“The insulin-like growth factors (IGF-I and -II) are ubiquitous polypeptides, involved in cell proliferation and survival (1, 2).”
BackgroundLawrence, J. B., Oxvig, C., Overgaard, M. T., Sottrup-Jensen, L., Gleich, G. J., Hays, L. G., Yates, J. R., & Conover, C. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3149 · Cited by 706
Self-citationThe GH/IGF-1 axis in ageing and longevity
Junnila, R. K., List, E. O., Berryman, D. E., Murrey, J. W., & Kopchick, J. J. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.67 · Cited by 574 · cited 1×
“Similar to several other genes of the IGF axis, the absence of PAPP-A causes a markedly (35%) increased healthy life span in mice (23).”
BackgroundPregnancy-Associated Plasma Protein A as a Marker of Acute Coronary Syndromes
Bayes-Genis, A., Conover, C. A., Overgaard, M. T., Bailey, K. R., Christiansen, M., Holmes, D. R., Virmani, R., Oxvig, C., & Schwartz, R. S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa003147 · Cited by 561 · cited 1×
“PAPP-A is not only important in development, it is also thought to be involved in vascular disease in humans (19), and PAPP-A knock-out mice show resistance to the development of atherosclerotic lesions (20), diabetic nephropathy (21), and cancer (22).”
BackgroundSelf-citationThe Role of Liver-Derived Insulin-Like Growth Factor-I
Ohlsson, C., Mohan, S., Sjögren, K., Tivesten, A., Isgaard, J., Isaksson, O., Jansson, J.-O., & Svensson, J. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0010 · Cited by 453 · cited 2×
“The insulin-like growth factors (IGF-I and -II) are ubiquitous polypeptides, involved in cell proliferation and survival (1, 2).”
BackgroundConover, C. A., Bale, L. K., Overgaard, M. T., Johnstone, E. W., Laursen, U. H., Füchtbauer, E.-M., Oxvig, C., & van Deursen, J. (2004) · Development · doi:10.1242/dev.00997 · Cited by 302 · cited 3×
“From previous studies, it is known that although both transgenic overexpression of STC2 (27) and knock-out of PAPP-A (17) cause severe growth retardation, STC2 knock-out mice (28) are larger than wild-type mice.”
BackgroundResultSelf-citationLaursen, L. S., Overgaard, M. T., Søe, R., Boldt, H. B., Sottrup-Jensen, L., Giudice, L. C., Conover, C. A., & Oxvig, C. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02760-0 · Cited by 289 · cited 3×
“PAPP-A functions intimately with IGFBP-4 (8, 10 –15), and highly specific IGF-dependent (8) proteolytic cleavage by surface-tethered PAPP-A releases bioactive IGF from the inactive IGF IGFBP-4 complex in close proximity to the receptor (16).”
BackgroundSelf-citationOvergaard, M. T., Boldt, H. B., Laursen, L. S., Sottrup-Jensen, L., Conover, C. A., & Oxvig, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102191200 · Cited by 267 · cited 3×
“Likewise, further analysis is required to determine whether the STCs possess inhibitory activity toward other proteinases, including PAPP-A2 (51), the only paralog of PAPP-A.”
BackgroundSelf-citationBRCA1 transcriptionally regulates genes involved in breast tumorigenesis
Welcsh, P. L., Lee, M. K., Gonzalez-Hernandez, R. M., Black, D. J., Mahadevappa, M., Swisher, E. M., Warrington, J. A., & King, M.-C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062181799 · Cited by 256 · cited 1×
“For example, loss of BRCA1 tumor suppressor function in breast cancer causes STC1 expression to become undetectable (54), and late relapse of breast cancer correlates with high expression of STC1 and STC2 (55).”
BackgroundEvolution and roles of stanniocalcin
Yeung, B. H. Y., Law, A. Y. S., & Wong, C. K. C. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.11.007 · Cited by 230 · cited 1×
“It is therefore interesting that multiple reports link both stanniocalcins to human cancers, although both up- and down-regulations have been reported (24, 26).”
BackgroundHuman stanniocalcin: a possible hormonal regulator of mineral metabolism.
Olsen, H. S., Cepeda, M. A., Zhang, Q. Q., Rosen, C. A., & Vozzolo, B. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.1792 · Cited by 211 · cited 1×
“The two homologous STCs have unique amino acid sequences (47, 48), containing no known modules or motifs by which this biochemical function might have been predicted.”
BackgroundArchitecture and function of metallopeptidase catalytic domains
Cerdà‐Costa, N., & Xavier Gomis‐Rüth, F. (2014) · Protein Science · doi:10.1002/pro.2400 · Cited by 209 · cited 1×
“79), a member of the metzincin superfamily of metalloproteinases (6), that is able to cleave IGFBP-4 (7), IGFBP-5 (8), and IGFBP-2 (9).”
BackgroundInsulin-Like Growth Factor Binding Proteins: A Structural Perspective
Forbes, B. E., McCarthy, P., & Norton, R. S. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00038 · Cited by 189 · cited 1×
“IGF signaling is mediated by the type 1 IGF receptor (IGF1R),(3) but six high affinity IGF-binding proteins, IGFBP-1 to 6, are able to sequester the IGFs from the receptor (3, 4).”
BackgroundMammalian stanniocalcins and cancer.
Chang, A. C.-M., Jellinek, D., & Reddel, R. R. (2003) · Endocrine Related Cancer · doi:10.1677/erc.0.0100359 · Cited by 173 · cited 1×
“It is therefore interesting that multiple reports link both stanniocalcins to human cancers, although both up- and down-regulations have been reported (24, 26).”
BackgroundOvergaard, M. T., Haaning, J., Boldt, H. B., Olsen, I. M., Laursen, L. S., Christiansen, M., Gleich, G. J., Sottrup-Jensen, L., Conover, C. A., & Oxvig, C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001384200 · Cited by 172 · cited 1×
“(29), murine PAPP-A (30), and human IGFBP-4 (10) were reported elsewhere.”
BackgroundSelf-citationDerived variants at six genes explain nearly half of size reduction in dog breeds
Rimbault, M., Beale, H. C., Schoenebeck, J. J., Hoopes, B. C., Allen, J. J., Kilroy-Glynn, P., Wayne, R. K., Sutter, N. B., & Ostrander, E. A. (2013) · Genome Research · doi:10.1101/gr.157339.113 · Cited by 170 · cited 1×
“It was found that the occurrence of derived variants at only six genes is a major explanation for the extreme reduction in body size of dogs caused by selective breeding (46).”
BackgroundBoldt, H. B., Overgaard, M. T., Laursen, L. S., Weyer, K., Sottrup‐Jensen, L., & Oxvig, C. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3580359 · Cited by 167
Self-citationSitar, T., Popowicz, G. M., Siwanowicz, I., Huber, R., & Holak, T. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605652103 · Cited by 163 · cited 1×
“However, bioactive IGF can be released by means of proteolytic cleavage of the binding protein, causing the generation of IGFBP fragments with diminished affinity for IGF (5).”
BackgroundHarrington, S. C., Simari, R. D., & Conover, C. A. (2007) · Circulation Research · doi:10.1161/circresaha.106.146183 · Cited by 146 · cited 1×
“PAPP-A is not only important in development, it is also thought to be involved in vascular disease in humans (19), and PAPP-A knock-out mice show resistance to the development of atherosclerotic lesions (20), diabetic nephropathy (21), and cancer (22).”
BackgroundEarly-pregnancy origins of low birth weight
Smith, G. C. S., Stenhouse, E., Crossley, J. A., Aitken, D. A., Cameron, A. D., & Connor, J. M. (2002) · Nature · doi:10.1038/417916a · Cited by 138
Gagliardi, A. D., Kuo, E. Y. W., Raulic, S., Wagner, G. F., & DiMattia, G. E. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00268.2004 · Cited by 134 · cited 4×
“lating IGF-I is not altered in mice that have become dwarfs as a result of STC2 overexpression (27).”
BackgroundInfluentialAn Integrin–Contactin Complex Regulates CNS Myelination by Differential Fyn Phosphorylation
Laursen, L. S., Chan, C. W., & ffrench-Constant, C. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5942-08.2009 · Cited by 133 · cited 1×
“Transgenic STC2 contained in the media of confluent plates was immunoprecipitated from 20 ml of media using 30 l of protein G-Sepharose 4 Fast Flow (GE Healthcare), to which mAb STC221 was immobilized at 2 mg/ml by using dimethyl pimelimidate dihydrochloride (Sigma) cross-linking, essentially as described (33).”
MethodSelf-citationOverexpression of Human Stanniocalcin Affects Growth and Reproduction in Transgenic Mice
Varghese, R., Gagliardi, A. D., Bialek, P., Yee, S., Wagner, G. F., & DiMattia, G. E. (2002) · Endocrinology · doi:10.1210/endo.143.3.8671 · Cited by 123
Ning, Y., Schuller, A. G., Conover, C. A., & Pintar, J. E. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0536 · Cited by 123
Oxvig, C., Sand, O., Kristensen, T., Kristensen, L. J., & Sottrup‐Jensen, L. (1994) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(94)90071-x · Cited by 107 · cited 1×
“Primary Antibodies—For Western blotting, the following antibodies were used: rabbit polyclonal anti-(human PAPP-A) (35); mouse monoclonal anti-(c-Myc) (9E10, ATCC); goat polyclonal anti-(human STC2) (R&D Systems, AF2830); mouse monoclonal PY99 (Santa Cruz Biotechnology, sc-7020) for detection of phosphotyrosine residu…”
BackgroundSelf-citationLaursen, L. S., Kjær-Sørensen, K., Andersen, M. H., & Oxvig, C. (2007) · Molecular Endocrinology · doi:10.1210/me.2006-0522 · Cited by 99 · cited 3×
“PAPP-A functions intimately with IGFBP-4 (8, 10 –15), and highly specific IGF-dependent (8) proteolytic cleavage by surface-tethered PAPP-A releases bioactive IGF from the inactive IGF IGFBP-4 complex in close proximity to the receptor (16).”
BackgroundMethodSelf-citationLongevity and Age-Related Pathology of Mice Deficient in Pregnancy-Associated Plasma Protein-A
Conover, C. A., Bale, L. K., Mader, J. R., Mason, M. A., Keenan, K. P., & Marler, R. J. (2010) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glq032 · Cited by 99 · cited 2×
“PAPP-A is not only important in development, it is also thought to be involved in vascular disease in humans (19), and PAPP-A knock-out mice show resistance to the development of atherosclerotic lesions (20), diabetic nephropathy (21), and cancer (22).”
BackgroundInsights into Morphology and Disease from the Dog Genome Project
Schoenebeck, J. J., & Ostrander, E. A. (2014) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100913-012927 · Cited by 98 · cited 1×
“Similar findings have recently resulted from genetic studies of domestic dogs, which show the greatest variation in body size of any land mammal (45).”
ResultThe Murine Stanniocalcin 2 Gene Is a Negative Regulator of Postnatal Growth
Chang, A. C.-M., Hook, J., Lemckert, F. A., McDonald, M. M., Nguyen, M.-A. T., Hardeman, E. C., Little, D. G., Gunning, P. W., & Reddel, R. R. (2008) · Endocrinology · doi:10.1210/en.2007-1219 · Cited by 96 · cited 3×
“Of particular interest, mice overexpressing STC2 are reduced 45% in size (27), whereas STC2 knock-out mice are 15% larger than wild-type littermates (28).”
BackgroundQin, X., Wergedal, J. E., Rehage, M., Tran, K., Newton, J., Lam, P., Baylink, D. J., & Mohan, S. (2006) · Endocrinology · doi:10.1210/en.2006-1055 · Cited by 90 · cited 1×
“A strong anabolic effect of PAPP-A was also demonstrated by a markedly increased bone thickness upon targeted transgenic PAPP-A expression in osteoblasts (39) and similarly by a large increase in skeletal muscle mass upon muscle-specific transgenic expression of PAPP-A (40).”
BackgroundLaursen, L. S., Overgaard, M. T., Nielsen, C. G., Boldt, H. B., Hopmann, K. H., Conover, C. A., Sottrup‐Jensen, L., Giudice, L. C., & Oxvig, C. (2002) · Biochemical Journal · doi:10.1042/bj20020831 · Cited by 87
Self-citationTumor dormancy: Elevated expression of stanniocalcins in late relapsing breast cancer
Joensuu, K. M., Heikkilä, P., & Andersson, L. C. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.02.022 · Cited by 72 · cited 3×
“The stanniocalcins (STC1 and STC2) are widely expressed secreted glycoproteins.”
BackgroundBale, L. K., & Conover, C. A. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06259 · Cited by 70
The Murine Stanniocalcin 1 Gene Is Not Essential for Growth and Development
Chang, A. C.-M., Cha, J., Köentgen, F., & Reddel, R. R. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.23.10604-10610.2005 · Cited by 68 · cited 1×
“In this regard, it is interesting to note that transgenic overexpression of STC1 (49) also causes growth retardation, although STC1 knock-out mice are normal (50).”
BackgroundBoldt, H. B., Kjær-Sørensen, K., Overgaard, M. T., Weyer, K., Poulsen, C. B., Sottrup‐Jensen, L., Conover, C. A., Giudice, L. C., & Oxvig, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405222200 · Cited by 66
Self-citationMikkelsen, J. H., Resch, Z. T., Kalra, B., Savjani, G. V., Kumar, A., Conover, C. A., & Oxvig, C. (2014) · Oncotarget · doi:10.18632/oncotarget.1629 · Cited by 62 · cited 3×
“Also, the involvement of PAPP-A in cancer development is increasingly recognized (32), and is underscored by the finding that PAPP-A knock-out mice have a remarkably low incidence of spontaneous age-related tumors (22).”
BackgroundSelf-citationGyrup, C., & Oxvig, C. (2007) · Biochemistry · doi:10.1021/bi062229i · Cited by 57
Self-citationStanniocalcin: No Longer Just a Fish Tale
Gerritsen, M. E., & Wagner, G. F. (2005) · Vitamins and hormones · doi:10.1016/s0083-6729(05)70004-2 · Cited by 45 · cited 1×
“Numerous published studies have indicated the possible involvement of the two mammalian STCs in diverse biological processes such as cell proliferation, calcium regulation, and cancer development (24-26).”
BackgroundSøe, R., Overgaard, M. T., Thomsen, A. R., Laursen, L. S., Olsen, I. M. L., Sottrup‐Jensen, L., Haaning, J., Giudice, L. C., Conover, C. A., & Oxvig, C. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.02883.x · Cited by 40 · cited 1×
“Plasmid constructs encoding human PAPP-A (29), murine PAPP-A (30), and human IGFBP-4 (10) were”
BackgroundSelf-citationWeyer, K., Boldt, H. B., Poulsen, C. B., Kjær-Sørensen, K., Gyrup, C., & Oxvig, C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607903200 · Cited by 40
Self-citationRehage, M., Mohan, S., Wergedal, J. E., Bonafede, B., Tran, K., Hou, D., Phang, D., Kumar, A., & Qin, X. (2007) · Endocrinology · doi:10.1210/en.2007-0274 · Cited by 36 · cited 1×
“A strong anabolic effect of PAPP-A was also demonstrated by a markedly increased bone thickness upon targeted transgenic PAPP-A expression in osteoblasts (39) and similarly by a large increase in skeletal muscle mass upon muscle-specific transgenic expression of PAPP-A (40).”
BackgroundLow-resolution structural studies of human Stanniocalcin-1
Trindade, D. M., da Silva, J. C., Navarro, M. S., Torriani, I. L., & Kobarg, J. (2009) · BMC Structural Biology · doi:10.1186/1472-6807-9-57 · Cited by 27 · cited 2×
“Disulfide bonds and dimerization disulfide of STC1, indicated by lines, are according to published data (38).”
Mice deficient in PAPP-A show resistance to the development of diabetic nephropathy
Mader, J. R., Resch, Z. T., McLean, G. R., Mikkelsen, J. H., Oxvig, C., Marler, R. J., & Conover, C. A. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0167 · Cited by 26 · cited 1×
“PAPP-A is not only important in development, it is also thought to be involved in vascular disease in humans (19), and PAPP-A knock-out mice show resistance to the development of atherosclerotic lesions (20), diabetic nephropathy (21), and cancer (22).”
BackgroundSelf-citationMikkelsen, J. H., Steffensen, L. B., & Oxvig, C. (2013) · Journal of Immunological Methods · doi:10.1016/j.jim.2013.12.002 · Cited by 20 · cited 3×
“For Western blotting, the following antibodies were used: rabbit polyclonal anti-(human PAPP-A) (35); mouse monoclonal anti-(c-Myc) (9E10, ATCC); goat polyclonal anti-(human STC2) (R&D Systems, AF2830); mouse monoclonal PY99 (Santa Cruz Biotechnology, sc-7020) for detection of phosphotyrosine residues; mouse monoclona…”
BackgroundSelf-citation
Cited by
Rare and low-frequency coding variants alter human adult height
Marouli, E., Graff, M., Medina-Gomez, C., Lo, K. S., Wood, A. R., Kjaer, T. R., Fine, R. S., Lu, Y., Schurmann, C., Highland, H. M., et al. (2017) · Nature · doi:10.1038/nature21039 · Cited by 610
“Overexpression of STC2 diminishes growth in mice by covalent binding to and inhibition of the proteinase PAPP-A, which specifically cleaves insulin growth factor binding protein 4 (IGFBP-4), leading to reduced levels of bioactive insulin-like growth factors 23 (Fig.”
Self-citationThe role of PAPP-A in the IGF system: location, location, location
Oxvig, C. (2015) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-015-0259-9 · Cited by 198
“Furthermore, transgenic mice overexpressing a variant of STC2, in which a single amino acid has been substituted to eliminate its ability to inhibit PAPP-A, grow like wild-type mice (Jepsen et al. 2014).”
BackgroundInfluentialSelf-citationHernandez Cordero, A. I., Gonzales, N. M., Parker, C. C., Sokolof, G., Vandenbergh, D. J., Cheng, R., Abney, M., Sko, A., Douglas, A., Palmer, A. A., et al. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.10.014 · Cited by 59
Metadata
- Authors
- Jepsen, M. R., Kløverpris, S., Mikkelsen, J. H., Pedersen, J. H., Füchtbauer, E.-M., Laursen, L. S., & Oxvig, C.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2015-02
- Volume
- 290
- Issue
- 6
- Pages
- 3430-3439
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2074444846
- Cited by
- 166
- References
- 52
- FWCI
- 4.79
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.